Report an error

Spotted something inaccurate in “GLP-1 Weight-Loss Drugs Linked to Emerging Eating Disorder Risk Signals”? Tell us what’s wrong and we’ll check it against the original source.

Cancel

This form is for factual corrections. We read every report but cannot reply individually.